Nasal Intermittent Positive Pressure Ventilation with Heliox in Premature Infants with Respiratory Distress Syndrome: A Randomized Controlled Trial.
Indian Pediatr
;
2014 Nov; 51(11): 900-902
Article
in English
| IMSEAR
| ID: sea-170902
ABSTRACT
Objective:
To assess the efficacy of nasal intermittent positive pressure ventilation with heliox in preterm infants with respiratory distress syndrome.Methods:
Premature infants with mild respiratory distress syndrome requiring non-invasive respiratory support were eligible. Infants were randomly assigned to heliox or air-oxygen group. The main outcome was the length of ventilation.Results:
Heliox significantly decreased the length of ventilation. The length of ventilation was positively correlated with interleukin-6 at baseline. Carbon dioxide elimination was better in the heliox group.Conclusion:
Heliox delivered with nasal intermittent positive pressure ventilation may be effective in reducing length of ventilation and increasing carbon dioxide elimination.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Type of study:
Controlled clinical trial
Language:
English
Journal:
Indian Pediatr
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS